Medicare Advantage health plan building in-house data and AI capabilities
Astiva Health is an Orange, California Medicare Advantage plan whose stack pairs a Microsoft data layer (SQL Server, SSIS, SSRS, Power BI) with LLM fine-tuning tools like PyTorch, LoRA, QLoRA, PEFT and RAG on Azure AI, which is unusual for an 11–50 person payer. Accelerating, support-heavy hiring and job-post themes around HEDIS, RAF and claims accuracy point to a plan focused on quality scores and claims operations.
Astiva Health, Inc is a privately held Medicare Advantage health plan headquartered in Orange, California, with 11–50 employees. It serves Medicare-eligible members and works closely with a provider network and insurance brokers. Current work spans provider education, quality programs tied to HEDIS and Star ratings, claims operations, and broker-facing marketing. Hiring is concentrated in the United States, mainly in support and healthcare roles, with smaller openings in data, HR, marketing and sales.
Astiva Health uses SQL Server, SSIS, SSRS and Power BI for data and reporting, Python with PyTorch, TensorFlow and scikit-learn, Azure AI with RAG and LoRA/QLoRA/PEFT, plus Monday.com, Hootsuite, Canva and Adobe tools.
Yes. Hiring is accelerating, mostly for mid-level support and healthcare roles in the United States, with additional openings in data, HR, marketing and sales.
Job posts point to HEDIS and RAF initiatives, dashboards for HEDIS and Star ratings, automated ETL workflows for reporting, claims data validation, provider education meetings and broker portal updates.
Other companies in the same industry, closest in size
Astiva Health, Inc's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.